SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3%
Wed, 14 Aug

SUN PHARMA has announced its results for the quarter ended June 2019. Here is a detailed performance review of the same:

SUN PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-18*
3
Mar-19*
3
Jun-19*
QoQ ChangeYoY Change
Net SalesRs m72,24271,63983,74416.9%15.9%
Other incomeRs m1,9982,8152,130-24.3%6.6%
TurnoverRs m74,23974,45585,87415.3%15.7%
ExpensesRs m56,17561,47163,7883.8%13.6%
Gross profitRs m16,06710,16819,95696.3%24.2%
DepreciationRs m4,0164,5414,5710.7%13.8%
InterestRs m1,3091,5001,041-30.6%-20.5%
Profit before taxRs m12,7396,94216,474137.3%29.3%
TaxRs m1,639-2881,461-10.9%
Profit after taxRs m11,1017,23115,014107.6%35.3%
Gross profit margin%22.214.223.8
Effective tax rate%12.9-4.18.9
Net profit margin%15.09.717.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 15.9% on a year-on-year (YoY) basis. The expenses were up by 13.6% YoY during the same period.
  • The company's operating profit increased by 24.2% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 23.8% in 1QFY20 as against 22.2% in 1QFY19.
  • Depreciation charges increased by 13.8% and finance costs declined by 20.5% YoY, respectively.
  • Other income increased by 6.6% YoY during the quarter.
  • Net profit for the quarter increased by 35.3% YoY. Net profit margins during the quarter increased from 15.0% in 1QFY19 to 17.5% in 1QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 16.9% on a quarter-on-quarter (QoQ) basis. The expenses were up by 3.8% QoQ during the same period.
  • The company's operating profit increased by 96.3% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 23.8% in 1QFY20 as against 14.2% in 4QFY19.
  • Net profit for the quarter increased by 107.6% QoQ, while net profit margins increased from 9.7% in 4QFY19 to 17.5% in 1QFY20.

To see how SUN PHARMA has performed over the last eight quarters,please visit here.

SUN PHARMA Share Price Performance

Over the last one year,SUN PHARMA share price has moved down from Rs 601.7 to Rs 416.7, registering a Loss of Rs 185.0 or around 30.7%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 12,484.3 (down 0.7%). Over the last one year it has moved down from 14,687.0 to 12,484.3, a gain of 2,203 points (down 15.0%).

Overall, the S&P BSE SENSEX is down 0.6% over the year.

Current Valuations

At the current price of Rs 416.7, the price to earnings (P/E) ratio of SUN PHARMA stands at 28.0 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.4 times.

Equitymaster requests your view! Post a comment on "SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3%". Click here!

  

Related Views on News

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Jan 20, 2021 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUN PHARMA WITH

MARKET STATS